Michelle N. Bradley - Concepedia

Concepedia

Author

Michelle N. Bradley

University of California, Los Angeles

Also Known As

Michelle Bradley, Michelle N Bradley, Michelle N. Bradley

20

Publications

4.7K

Citations

18

H-Index

45

Concepts

All Affiliations

University of California, Los Angeles Howard Hughes Medical Institute Délégation Paris 5 Université Paris Cité Université Laval

MN

About

Michelle N. Bradley is an author at University of California, Los Angeles specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	3.6K
2	Immunology	8	8	2.7K
3	Cell Biology	7	7	2.6K
4	Biochemistry	1	1	65
5	Cellular Physiology	1	1	49

Michelle N. Bradley

×

18

Publications

4.7K

Citations

18

H-Index

	Year	Citations
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi, The Lancet Diabetes & Endocrinology Bone DiseaseDenosumab TreatmentBone HealthPhase 3Osteopathy	2017	916
LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response Steven J. Bensinger, Michelle N. Bradley, Sean B. Joseph, Cell InflammationSignal TransductionMolecular PhysiologyOxysterolMedicine	2008	706
Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR Noelia A-González, Steven J. Bensinger, Cynthia Hong, Immunity Nuclear Receptor LxrImmune ToleranceAutoimmune DiseaseImmunologyCell Death	2009	657
LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response Sean B. Joseph, Michelle N. Bradley, Antonio Castrillo, Cell InflammationMacrophage SurvivalImmune Cell DevelopmentInnate Immune SystemImmunology	2004	565
Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati, Journal of Bone and Mineral Research	2011	340
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development Satoko Arai, John M. Shelton, Mingyi Chen, Cell Metabolism InflammationVascular DiseaseAtherosclerosis DevelopmentCardiovascular DiseaseAtherosclerosis	2005	291
The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension Henry G. Bone, Roland Chapurlat, Maria Luisa Brandi, The Journal of Clinical Endocrinology & Metabolism	2013	249
LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression Jonathan E. Feig, Inès Pineda‐Torra, Marie Sanson, Journal of Clinical Investigation Maximal EgressVascular DiseaseImmunologyPathologyInflammation	2010	186
Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event Amy S. Weinmann, Deborah M. Mitchell, Shomyseh Sanjabi, Nature Immunology ChromatinTranscriptional RegulationNucleosome RemodelingChromatin RemodelingRel-independent Event	2001	160
C/EBPβ Regulation in Lipopolysaccharide-Stimulated Macrophages Michelle N. Bradley, Liang Zhou, Stephen T. Smale Molecular and Cellular Biology	2003	112

Page 1